US FDA’s COVID Master Protocol Guidance To Maintain Influence Post-Pandemic

 
• By Derrick Gingery

Agency seeking comment on document intended to replace the just-issued guidance on COVID-19 treatment development as FDA stresses the value of master protocols for developing clinical knowledge.

Clinical research
Drugs evaluated in a master protocol are expected to have already been tested in humans, the FDA said in the guidance. • Source: Alamy

More from Clinical Trials

More from R&D